Cogent Biosciences (COGT) Receivables - Net (2017 - 2019)

Cogent Biosciences (COGT) has 3 years of Receivables - Net data on file, last reported at $2.0 million in Q4 2019.

• On a quarterly basis, Receivables - Net rose 19.9% year-over-year to $2.0 million in Q4 2019; TTM through Dec 2019 was $2.0 million, a 19.9% increase from a year earlier, with the FY2019 full-year figure at $2.0 million, up 19.9% from the prior year.
• Receivables - Net for Q4 2019 stood at $2.0 million, up from $880000.0 in the prior quarter.
• Over the last five years, Receivables - Net for COGT reached as high as $2.0 million in Q1 2019 and fell as low as $830000.0 in Q4 2017.
• Historically, Receivables - Net has averaged $1.5 million across 3 years, with a median of $1.5 million in 2019.
• Across the five-year window, Receivables - Net jumped 100.96% in 2018 and plunged 37.98% in 2019, its largest moves.
• Year by year, Receivables - Net stood at $830000.0 in 2017, then soared by 100.96% to $1.7 million in 2018, then advanced by 19.9% to $2.0 million in 2019.
• Per Business Quant data, the three most recent Receivables - Net figures were $2.0 million in Q4 2019, $880000.0 in Q3 2019, and $1.5 million in Q2 2019.